Trials / Not Yet Recruiting
Not Yet RecruitingNCT07269392
Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer
Impact of Dual Trigger Using Recombinant Human Chorionic Gonadotropin (HCG) and Gonadotropin-releasing Hormone (GnRH) Agonist on Thawed Modified Natural Cycle Outcomes: an Open-label Multi-center Randomized Controlled Trial.
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- Female
- Age
- 25 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
Impact of dual trigger using recombinant human chorionic gonadotropin (HCG) and gonadotropin-releasing hormone (GnRH) agonist on thawed modified natural cycle outcomes: an open-label multi-center randomized controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GnRH agonist | GnRH agonist add to hcg for trigger |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2028-12-31
- Completion
- 2029-12-31
- First posted
- 2025-12-08
- Last updated
- 2025-12-16
Source: ClinicalTrials.gov record NCT07269392. Inclusion in this directory is not an endorsement.